Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes.
Autoimmune disorders constitute a diverse group of phenotypes with overlapping features and a tendency toward familial aggregation. It is likely that common underlying genes are involved in these disorders. Until very recently, no specific alleles--aside from a few common human leukocyte antigen class II genes--had been identified that clearly associate with multiple different autoimmune diseases. In this study, we describe a unique collection of 265 multiplex families assembled by the Multiple Autoimmune Disease Genetics Consortium (MADGC). At least two of nine "core" autoimmune diseases are present in each of these families. These core diseases include rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), type 1 diabetes (T1D), multiple sclerosis (MS), autoimmune thyroid disease (Hashimoto thyroiditis or Graves disease), juvenile RA, inflammatory bowel disease (Crohn disease or ulcerative colitis), psoriasis, and primary Sjogren syndrome. We report that a recently described functional single-nucleotide polymorphism (rs2476601, encoding R620W) in the intracellular tyrosine phosphatase (PTPN22) confers risk of four separate autoimmune phenotypes in these families: T1D, RA, SLE, and Hashimoto thyroiditis. MS did not show association with the PTPN22 risk allele. These findings suggest a common underlying etiologic pathway for some, but not all, autoimmune disorders, and they suggest that MS may have a pathogenesis that is distinct from RA, SLE, and T1D. DNA and clinical data for the MADGC families are available to the scientific community; these data will provide a valuable resource for the dissection of the complex genetic factors that underlie the various autoimmune phenotypes.
Criswell
Lindsey A
LA
Rosalind Russell Medical Research Center for Arthritis, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
Pfeiffer
Kirsten A
KA
Lum
Raymond F
RF
Gonzales
Bonnie
B
Novitzke
Jill
J
Kern
Marlena
M
Moser
Kathy L
KL
Begovich
Ann B
AB
Carlton
Victoria E H
VE
Li
Wentian
W
Lee
Annette T
AT
Ortmann
Ward
W
Behrens
Timothy W
TW
Gregersen
Peter K
PK
D001327:Autoimmune Diseases / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease; D006684:HLA-DR Antigens / Q000235:genetics; D006650:Histocompatibility Testing; D006801:Humans; D008297:Male; D020641:Polymorphism, Single Nucleotide; D054562:Protein Tyrosine Phosphatase, Non-Receptor Type 1; D054596:Protein Tyrosine Phosphatase, Non-Receptor Type 22; D017027:Protein Tyrosine Phosphatases / Q000235:genetics*; D012042:Registries; D012737:Sex Factors
D006684:HLA-DR Antigens; C516765:PTPN22 protein, human; D054562:Protein Tyrosine Phosphatase, Non-Receptor Type 1; D054596:Protein Tyrosine Phosphatase, Non-Receptor Type 22; D017027:Protein Tyrosine Phosphatases
Nat Genet. 2004 Apr;36(4):337-8
15004560
Genes Immun. 2005 Mar;6(2):129-33
15674368
J Urban Health. 2004 Jun;81(2):301-10
15136663
N Engl J Med. 2004 May 13;350(20):2068-79
15141045
Arthritis Rheum. 2004 Jun;50(6):1770-3
15188352
Mol Immunol. 2004 Jul;41(6-7):687-700
15220004
Am J Hum Genet. 2004 Sep;75(3):504-7
15273934
Am J Hum Genet. 2004 Aug;75(2):330-7
15208781
Diabetes. 2004 Nov;53(11):3020-3
15504986
Proc Natl Acad Sci U S A. 2004 Oct 26;101(43):15464-9
15489265
Am J Hum Genet. 1986 Feb;38(2):170-87
3456197
Trends Genet. 1988 May;4(5):129-34
3070863
Eur J Immunogenet. 1991 Feb-Apr;18(1-2):33-55
2069944
J Rheumatol. 1993 Nov;20(11):1830-5
8308766
Am J Ind Med. 1995 Nov;28(5):603-8
8561170
QJM. 1996 Nov;89(11):821-9
8977961
Eur J Hum Genet. 1997 Mar-Apr;5(2):69-77
9195155
Arthritis Rheum. 1997 Nov;40(11):1955-61
9365083
Arthritis Rheum. 1998 Mar;41(3):400-5
9506566
J Biol Chem. 1998 May 22;273(21):13217-22
9582365
Am J Hum Genet. 1998 Jul;63(1):259-66
9634505
Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):9979-84
9707586
Curr Opin Rheumatol. 1998 Sep;10(5):399-408
9746854
Ann Rheum Dis. 1998 Aug;57(8):451-5
9797548
Hum Genet. 1998 Oct;103(4):475-82
9856493
J Exp Med. 1999 Jan 4;189(1):111-21
9874568
J Rheumatol. 1999 Jan;26(1):47-54
9918239
Brain. 2000 Jun;123 ( Pt 6):1102-11
10825350
Arthritis Rheum. 2001 May;44(5):1122-6
11352244
Am J Pathol. 2001 Sep;159(3):787-93
11549568
J Leukoc Biol. 2001 Oct;70(4):578-84
11590194
Eur J Endocrinol. 2002 Feb;146(2):153-61
11834423
Curr Opin Allergy Clin Immunol. 2001 Oct;1(5):399-405
11964719
Rheumatology (Oxford). 2002 May;41(5):563-71
12011382
Am J Hum Genet. 2002 Sep;71(3):543-53
12145745
Am J Hum Genet. 2002 Sep;71(3):585-94
12181776
Nat Genet. 2002 Dec;32(4):666-9
12402038
Am J Hum Genet. 2003 Mar;72(3):710-6
12557126
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2610-5
12604793
Nature. 2003 May 29;423(6939):506-11
12724780
Clin Endocrinol (Oxf). 2003 Sep;59(3):396-401
12919165
N Engl J Med. 2003 Oct 16;349(16):1526-33
14561795
Neurology. 2003 Oct 28;61(8):1122-4
14581676
Tissue Antigens. 2003 Dec;62(6):492-7
14617032
Science. 2004 Jan 30;303(5658):685-9
14752163
Arthritis Rheum. 2004 Feb;50(2):380-6
14872479
Tissue Antigens. 2004 Mar;63(3):237-47
14989713
Arthritis Rheum. 2004 Mar;50(3):736-41
15022313
Arthritis Rheum. 2004 Mar;50(3):770-5
15022318
Clin Exp Immunol. 2004 Apr;136(1):120-8
15030523
Arthritis Rheum. 1999 Aug;42(8):1782-3
10446885
J Clin Endocrinol Metab. 2004 Nov;89(11):5862-5
15531553
Am J Hum Genet. 2005 Jan;76(1):184-7
15580548
J Clin Invest. 2004 Mar;113(6):788-94
15067307